CPT® Code 82101

Code deleted, see 80323

Official Description

Alkaloids, urine, quantitative

Common Language Description

The CPT® Code 82101 refers to a laboratory test that quantitatively measures alkaloids in urine. Alkaloids are a class of naturally occurring organic compounds that often have significant pharmacological effects. This test is particularly relevant in the context of substance abuse monitoring and chronic pain management. It is designed to detect the presence of alkaloid end-products resulting from the ingestion of various drugs or medications, including but not limited to codeine, morphine, cocaine, tobacco, and certain herbal substances. The quantitative aspect of this test is crucial as it provides a measurable evaluation of alkaloid levels in the urine, which can inform clinical decisions regarding a patient's treatment plan. The test is indicated in several scenarios: when there is a medically necessary reason to monitor a patient for drug use, when a qualitative test returns negative results for a prescribed medication, after a positive qualitative test for a drug with potential for abuse that was not prescribed, or when a patient tests positive for illegal substances such as methamphetamine or cocaine. The quantitative results serve as a guide for clinical care, helping healthcare providers make informed decisions about ongoing treatment and management of the patient's condition. To perform the test, a urine sample is collected, which can be obtained either through a voided specimen or catheterization. The analysis of the urine sample is conducted using advanced techniques such as liquid chromatography-tandem mass spectrometry, ensuring accurate and reliable results.

1. Indications

The quantitative evaluation of urine alkaloids is indicated in the following scenarios:

Monitoring Substance Abuse A medically necessary reason to monitor a patient for drug or medication use, particularly in cases of suspected substance abuse.
Negative Qualitative Test When a qualitative test returns negative results for a prescribed medication, indicating the need for further investigation.
Positive Qualitative Test Following a positive qualitative test for a drug or medication with abuse potential that was not prescribed, necessitating a quantitative assessment.
Illegal Drug Detection When a patient has tested positive for illegal drugs such as methamphetamine or cocaine, requiring further evaluation of alkaloid levels.

2. Procedure

The procedure for conducting the quantitative urine alkaloid test involves several key steps:

Sample Collection A urine sample is obtained from the patient. This can be done through a voided specimen, where the patient provides a sample by urinating into a container, or through catheterization, where a catheter is inserted into the bladder to collect urine directly. The method of collection may depend on the clinical situation and the need for a sterile sample.
Sample Preparation Once the urine sample is collected, it is prepared for analysis. This may involve processes such as centrifugation to separate components of the urine and ensure that the sample is suitable for testing.
Testing Methodology The prepared urine sample is then analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). This advanced analytical technique allows for the precise measurement of alkaloid concentrations in the urine, providing quantitative results that can be used to guide clinical decisions.
Result Interpretation After the analysis is complete, the results are interpreted by qualified laboratory personnel. The quantitative data obtained from the test will indicate the levels of specific alkaloids present in the urine, which can inform healthcare providers about the patient's substance use and guide further management.

3. Post-Procedure

After the urine alkaloid test is completed, the patient may not require any specific post-procedure care, as the test is non-invasive and does not typically involve any risks. However, healthcare providers may discuss the results with the patient, especially if any alkaloids are detected that warrant further clinical action. Depending on the findings, additional follow-up testing or changes in the patient's treatment plan may be necessary. It is important for healthcare providers to ensure that patients understand the implications of the test results and any subsequent steps that may be required for their care.

Short Descr	ASSAY OF URINE ALKALOIDS
Medium Descr	ALKALOIDS URINE QUANTITATIVE
Long Descr	Alkaloids, urine, quantitative
Status Code	Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	9 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
APC Status Indicator	Items and Services Packaged into APC Rates
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	T1H - Lab tests - other (non-Medicare fee schedule)
MUE	Not applicable/unspecified.
CCS Clinical Classification	200 - Nonoperative urinary system measurements